Max Shulaker’s research exploits machine learning and data analytics to correlate changes in a patient’s breath with rapid detection of bacterial infection. His invention is a three-dimensional electronic chip that contains millions of unique gas sensors capable of monitoring and detecting volatile organic compounds in a patient’s breath. The chip will capture terabytes of information from the patient in real time, generating a unique response, or chemical “fingerprint”. If successful, the invention could enable earlier clinical intervention and a new generation of real-time personalized diagnostics.
Moore Inventor Fellows